Host-Parasite Relationship in Opportunistic Mycoses

References

• Rippon J. W. Medical Mycology. W. B. Saunders, Philadelphia 1982; 565
   Google Scholar
• Mikami Y., Fukshima K., Arai T., Abe F., Shibuya H., Omraura Y. Leucinostains, peptide mycotoxins produced by Paecilomyces lilacinus and their possible roles in fungal infections. Zbl. Bakt. Hyg. A 1984; 257: 275
   PubMedGoogle Scholar
• Anderson R. L., Carroll T. F., Harvey J. T., Myers M. G. Petriellidium boydii orbital and brain abscess treated with intravenous miconazole. Am. J. Ophthalmol. 1984; 97: 771
   PubMedGoogle Scholar
• Greer D. L. Basidiomycetes as agents of human infections: a review. Mycopathologia. 1979; 65: 133
   Google Scholar
• Rinaldi M. G. Invasive aspergillosis. Rev. Infect. Dis. 1983; 5: 1061
   PubMedGoogle Scholar
• Bardana E. J., Jr. The clinical spectrum of aspergillosis. I. Epidemiology pathogenicity, infection in animals, and immunology of Aspergillus. Crit. Rev. Clin. Lab. Sci. 1981; 13: 21
   PubMedGoogle Scholar
• Glimp R. A., Bayer A. S. Fungal pneumonias. III. Allergic bronchopulmonary aspergillosis. Chest 1981; 80: 85
   PubMed Web of Science ®Google Scholar
• Rosenberg M., Patterson R., Mintzer R., Cooper B. J., Roberts M., Harris K. E. Clinical and immunologic criteria for the diagnosis of allergic bronchopulmonary aspergillosis. Ann. Intern. Med. 1977; 86: 405
   PubMed Web of Science ®Google Scholar
• Patterson R., Greenberger P. A., Radin R. C., Roberts M. Allergic bronchopulmonary aspergillosis: staging as an aid to management. Ann. Intern. Med. 1982; 96: 286
   PubMed Web of Science ®Google Scholar
• Meyer R. D., Young L. S., Armstrong D., Yu B. Aspergillosis complicating neoplastic disease. Am. J. Med. 1973; 54: 6
   PubMed Web of Science ®Google Scholar
• Slevin M. L., Knowies G. K., Phillips M. J., Stansfeld A. G., Lister T. A. The air crescent sign of invasive pulmonary aspergillosis in acute leukemia. Thorax 1982; 37: 554
   PubMedGoogle Scholar
• Gross B. H., Spitz H. B., Felson B. The mural nodule in cavitary opportunistic pulmonary aspergillosis. Radiology 1982; 143: 619
   PubMedGoogle Scholar
• Glimp R. A., Bayer A. S. Pulmonary aspergilloma: diagnostic and therapeutic considerations. Arch. Intern. Med. 1983; 143: 303
   PubMed Web of Science ®Google Scholar
• Limba G., Hutt M. R. S. Aspergillus granuloma of the paranasal sinuses and bronchi in Malawi. Trop. Georgr. Med. 1981; 33: 169
   PubMedGoogle Scholar
• Orr D. P., Myerowitz R. L., Dubois P. J. Patho-radiologic correlation of invasive pulmonary aspergillosis in the compromised host. Cancer 1978; 41: 2028
   PubMed Web of Science ®Google Scholar
• D'Silva H., Burke J. F., Cho S. Y. Disseminated aspergillosis in a presumably immunocompetent host. JAMA 1982; 248: 1495
   PubMed Web of Science ®Google Scholar
• Williams D. M., Krick J. A., Remington J. A. Pulmonary infection in the compromised host. I. Am. Rev. Respir. Dis. 1976; 114: 359
   PubMed Web of Science ®Google Scholar
• Young R. C., Bennett J. E., Vogel C. L., Carbone P. P., De Vita V. T. Aspergillosis, the spectrum of the disease in 98 patients. Medicine 1970; 49: 147
   PubMed Web of Science ®Google Scholar
• Gustafson T. L., Schaffher W., Lavely G. B., Stratton C. W., Johnson H. K., Hutcheson R. H., Jr. Invasive aspergillosis in renal transplant recipients: correlation with corticosteroid therapy. J. Infect. Dis. 1983; 148: 230
   PubMed Web of Science ®Google Scholar
• Burton J. R., Zacherj J. B., Bessin R., Rathbun H. K., Greenougb W. B., III, Sterioff S., Wright J. R., Slavin R. E., Williams G. M. Aspergillosis in four renal transplant recipients: diagnosis and effective treatment with amphotercin B. Ann. Intern. Med. 1972; 77: 383
   PubMed Web of Science ®Google Scholar
• Kyriakideo G. K., Zinneman H. H., Hail W. H., Arora V. R., OeWolf W. C., Miller J. Immunologic monitoring and aspergillosis in renal transplant patients. Am. J. Surg. 1976; 131: 246
   PubMedGoogle Scholar
• Cohen M. S., Isturiz R. E., Malech H. L., Root R. K., Wilfert C. M., Gutman L., Buckley R. H. Fungal infection in chronic granulomatous disease: the importance of the phagocyte in defense against fungi. Am. J. Med. 1981; 71: 59
   PubMed Web of Science ®Google Scholar
• Levitz S. M., Diamond R. D. Changing patterns of aspergillosis infections. Advances in Internal Medicine, G. H. Stollerman, W. J. Harrington, J. T. Lamont, J. F. Leonard, M. D. Siperstein. Year Book Medical Publishers, Chicago 1984; Vol. 30: 153
   Google Scholar
• Binder R. E., Faling L. J., Pugatch R. D., Mahasaen C., Snider G. L. Chronic necrotizing pulmonary aspergillosis: a discrete clinical entity. Medicine 1982; 61
   Google Scholar
• Gefter W. B., Wingrad T. R., Epstein D. M., Ochs R. H., Miller W. T. Semi-invasive pulmonary aspergillosis. Radiology 1981; 140: 313
   PubMed Web of Science ®Google Scholar
• Lehrer R. I., Howard D. H., Sypherd P. S., Edwards J. E., Segal J. P., Winston D. J. Mucormycosis. Ann. Intern. Med. 1980; 93: 93
   PubMed Web of Science ®Google Scholar
• Meyer R. D., Rosen P., Armstrong D. Phycomycosis complicating leukemia and lymphoma. Ann. Intern. Med. 1972; 77: 872
   Google Scholar
• Abramson E., Wilson D., Arkey R. A. Rhinocerebral phycomycosis in association with diabetic ketoacidosis: report of two cases and a review of clinical and experimental experience with amphotercin B therapy. Ann. Intern. Med. 1867; 66: 735
   Google Scholar
• Abedi E., Sismanis A., Choi K., Pastore P. Twenty-five years experience treating cerebral-rhino-orbital mucormycosis. Laryngoscope 1984; 94: 1060
   PubMed Web of Science ®Google Scholar
• Stahel R. A., Vogt P., Schuler G., Ruttner J. R., Frick P., Oelz O. Systemic fungal infections in hematological malignancies; a growing problem. J. Infect. 1982; 5: 269
   Web of Science ®Google Scholar
• Hale L. M. Orbital phycomycosis. South. Med. J. 1979; 63: 886
   Google Scholar
• Pollock R. A., Pratt R. C., Shulman J. A., Turner J. S. Nasal mucormycosis: early detection and treatment without radical surgery or amphotercin B. South. Med. J. 1975; 68: 1279
   PubMed Web of Science ®Google Scholar
• Pillsbury H. C., Fisher N. D. Rhinocerebral mucormycosis. Arch. Otolaryngol. 1977; 103: 600
   PubMedGoogle Scholar
• Gale A. M., Kleitsch W. P. Solitary pulmonary nodule due to phycomycosis (mucormycosis). Chest 1972; 62: 752
   PubMed Web of Science ®Google Scholar
• Meyer R. D., Armstrong D. Mucormycosis-changing status. Crit. Rev. Clin. Lab. Sci. 1973; 4: 421
   Google Scholar
• Kahn L. B. Gastric mucormycosis: report of a case with a review of the literature. S. Afr. Med. J. 1963; 37: 1265
   PubMedGoogle Scholar
• Aziz S., Merrell R. C., Edwards M. F. Mucormycosis in patients with multiple-organ failure. Arch. Surg. 1984; 119: 1189
   PubMedGoogle Scholar
• Montes L. F., Wilborn W. H. Fungus-host relationship in candidiasis. Arch. Dermatol. 1985; 121: 119
   PubMedGoogle Scholar
• Odds F. C. Ecology and epidemiology of Candida species. 2bl. Bakt. Hyg. A 1984; 257: 207
   PubMedGoogle Scholar
• Odds F. C., Abbott A. B., Stiller R. L., Scholer H. J., Polak A., Stevens D. A. Analysis of Candida albicansphenotypes from different geographical and anatomical sources. J. Clin. Microbiol. 1983; 18: 849
   PubMedGoogle Scholar
• Ahearn D. G. Medically important yeasts. Ann. Rev. Microbiol. 1978; 32: 59
   PubMedGoogle Scholar
• Schreiber J. R., Naynard E., Lew M. A. Candida antigen detection in two premature neonates with disseminated candidiasis. Pediatrics 1984; 74: 838
   PubMed Web of Science ®Google Scholar
• Corbel L., Ceuppens J. L., Van Den Berghe G., Claeys H., Casteels-van Daele M. Immunological observations before and after successful treatment of chronic mucocutaneous candidiasis with ketoconazole and transfer factor. Eur. J. Pediat. 1984; 143: 45
   PubMedGoogle Scholar
• Collins J. R., van Sickels J. E. Chronic mucocutaneous candidiasis. J. Oral Maxillofac. Surg. 1983; 41: 814
   PubMedGoogle Scholar
• Rogers T. J., Balish E. Immunity to. Candida albicans, Microbiol. Rev. 1980; 44: 660
   Google Scholar
• Hickey W. F., Sommerville L. H., Schoen F. J. Disseminated Candida glabratareport of a uniquely severe infection and a literature review. Am. J. Clin. Path. 1983; 80: 724
   PubMed Web of Science ®Google Scholar
• Pope L. M., Cole G. T. Comparative studies of gastrointestinal colonization and systemic spread by Candida albicans and nonlethal yeast in the infant mouse. Scanning Electron Microsc 1982; 4: 1667
   Google Scholar
• Barnes J. L., Osgood R. W., Lee J. C., King R. D., Stein J. H. Host-parasite interactions in the pathogenesis of experimental renal candidiasis. Lab. Invest. 1983; 49: 460
   PubMedGoogle Scholar
• Merkow L. P., Epstein S. M., Sidransky H., Verney E., Pando M. The pathogenesis of experimental pulmonary aspergillosis. An ultrastmctural study of alveolar macrophages after phagocytosis of Aspergillus flavus spores in vivo. Am. J. Pathol. 1971; 62: 57
   PubMed Web of Science ®Google Scholar
• Waldorf A. R., Leviu S. M., Diamond R. D. In vivo bronchoalveolar macrophage defense against Rhizopus oryzae and Aspergillus fumigatus. J. Infect. Dis. 1984; 150: 752
   PubMed Web of Science ®Google Scholar
• Schaffner A., Douglas H., Braude A. I., Davis C. E. Killing of Aspergillus spores depends on the anatomical source of the macrophage. Infect. Immun. 1983; 42: 1109
   PubMed Web of Science ®Google Scholar
• Schaffner A., Douglas H., Braude A. I. Selective protection against conidia by mononuclear and against mycelia by polymorphonuclear phagocytes in resistance to Aspergillus. Observations on these two lines of defense in vivoand in vitrowith human and mouse phagocytes. J. Clin. Invest. 1982; 69: 617
   PubMed Web of Science ®Google Scholar
• Kurup V. P. Interaction of A. fumigatus spores with pulmonary alveolar macrophages of rabbits. Immunobiology 1984; 166: 53
   PubMed Web of Science ®Google Scholar
• Monga D. P. Studies on experimental aspergillosis in immunodeficient mice. Zbl. Bakt. Hyg. I Abt. Orig. A. 1983; 254: 552
   Google Scholar
• Williams D. M., Weiner M. H., Drutz D. J. Immunologic studies of disseminated infection with A. fumigatus in the nude mouse. J. Infect. Dis. 1981; 143: 726
   PubMed Web of Science ®Google Scholar
• Merkow L. L., Prado M., Epstein S. M., Verney E., Sidransky H. Lysosomal stability during phagocytosis of Aspergillus flavus spores by alveolar macrophages of cortisone-treated mice. Science 1968; 160: 79
   PubMed Web of Science ®Google Scholar
• Waldorf A. R., Ruderman N., Diamond R. D. Specific susceptibility to mucormycosis in murine diabetes and bronchoalveolar macrophage defense against Rhizopus. J. Clin. Invest. 1984; 74: 150
   PubMed Web of Science ®Google Scholar
• Waldorf A. R., Diamond R. D. Cerebral mucormycosis in diabetic mice after intrasinus challenge. Infect. Immun. 1984; 44: 194
   PubMedGoogle Scholar
• Reinhardt D. J., Licata I., Kaplan W., Ajello L., Chandler F. W., Ellis J. J. Experimental cerebral zygomycosis in alloxan-diabetic rabbits: variation in virulence among zygomycetes. Sabouraudia. 1981; 19: 245
   PubMedGoogle Scholar
• Reinhardt D. J., Kaplan W., Ajello L. Experimental cerebral zygomycosis in alloxan-diabetic rabbits. I. Relationship of temperature tolerance of selected zygomycetes to pathogenicity. Infect. Immun. 1970; 2: 404
   PubMedGoogle Scholar
• Elder T. D., Baker R. D. Pulmonary mucormycosis in rabbits with alloxan diabetes. Arch. Pathol. 1956; 61: 159
   Google Scholar
• Baner H., Flanagan J. F., Sheldon W. H. Experimental cerebral mucormycosis in alloxan-diabetic rabbits. Yale J. Biol. Med. 1955; 28: 29
   PubMedGoogle Scholar
• Sheldon W. H., Bauer H. The development of the acute inflammatory response to experimental cutaneous mucormycosis in normal and diabetic rabbits. J. Exp. Med. 1959; 110: 845
   PubMed Web of Science ®Google Scholar
• Sheldon W. H., Bauer W. Tissue mast cells and acute inflammation' in experimental cutaneous mucormycosis of normal 48/80-treated and diabetic rats. J. Exp. Med. 1960; 112: 1069
   PubMedGoogle Scholar
• Waldorf A. R., Halde C., Vedros N. A. Murine model of pulmonary mucormycosis in cortisone-treated mice. Sabouraudia 1982; 20: 217
   PubMedGoogle Scholar
• Waldorf A. R., Peter L., Polak A. Mucormycotic infection in mice following prolonged incubation of spores in vivo and the role of spore agglutinating antibodies on spore germination. Sabouraudia 1983; 22: 101
   Google Scholar
• Smith J. M. In vivo development of spores of Absidia ramosa. Sabouraudia 1976; 14: 11
   PubMedGoogle Scholar
• Nugent K. M., Onofrio J. M. Pulmonary tissue resistance to Candida albicans in normal and in immunosuppressed mice. Am. Rev. Respir. Dis. 1983; 128: 909
   PubMedGoogle Scholar
• Peterson E., Calderone R. Growth inhibition of Candida albicans by rabbit alveolar macrophages. Infect. Immun. 1978; 15: 910
   Google Scholar
• Zeligs B. J., Nerurkar L. S., Bellanti J. A. Chemotactic and candidacidal responses of rabbit alveolar macrophages during development and the modulating roles of surfactant in these responses. Infect. Immun. 1984; 44: 379
   PubMed Web of Science ®Google Scholar
• Peterson E., Calderone R. Inhibition of specific amino acid uptake in Candida albicans by lysosomal extracts from rabbit alveolar macrophages. Infect. Immun. 1978; 21: 506
   PubMedGoogle Scholar
• Nugent K. M., Onofrio J. M. Pulmonary clearance of Candida albicans in neutropenic mice. J. Infect. Dis. 1984; 149: 27
   Google Scholar
• Lundborg M., Holma B. In vitro phagocytosis of fungal spores by rabbit lung macrophages. Sabouraudia 1972; 10: 152
   PubMedGoogle Scholar
• Levitz S. M., Diamond R. D. Killing of Aspergillus fumigatus spores and Candida albicans yeast phase by the iron-hydrogen peroxide-iodide cytotoxic system: comparison with the myeloperoxidase-hydrogen peroxide-halide system. Infect. Immun. 1984; 43: 1100
   PubMed Web of Science ®Google Scholar
• Klebanoff S. J. The iron-H2O2-iodide cytotoxic system. J. Exp. Med. 1982; 156: 1262
   PubMed Web of Science ®Google Scholar
• Leijh P. C. J., van den Barselarr M. T., van Furth R. Kinetics of phagocytosis and intracellular killing of Candida albicansby human granulocytes and monocytes. Infect. Immun. 1977; 17: 313
   PubMed Web of Science ®Google Scholar
• Kagaya K., Fukazawa Y. Murine defense mechanisms against Candida albicans infection. II. Opsonization, phagocytosis and intracellular killing of Candida albicans. Microbiol. Immunol. 1981; 25: 807
   PubMed Web of Science ®Google Scholar
• Stanley V. C., Hurley R. The growth of Candida species in cultures of mouse peritoneal macrophages. J. Pathol. 1969; 97: 357
   PubMedGoogle Scholar
• Belcher R. W., Carney J. F., Monahan F. G. An electron microscopic study of phagocytosis of Candida albicans by polymorphonuclear leukocytes. Lab. Invest. 1973; 29: 620
   PubMedGoogle Scholar
• Ishikawa T., Yu M. C., Arbesman C. E. Electron microscopic demonstration of phagocytosis of Candida albicansby human eosinophilic leukocytes. J. Allergy Clin. Immunol. 1972; 50: 183
   PubMedGoogle Scholar
• Ishikawa R. I., Dalton A. C., Arbesman C. E. Phagocytosis of Candida albicansby eosinophilic leukocytes. J. Allergy Clin. Immunol. 1972; 49: 311
   PubMed Web of Science ®Google Scholar
• Lehrer R. I. Measurement of candidacidal activity of specific leukocyte types in mixed cell populations. I. Normal, myeloperoxidase deficient, and chronic granulomatous disease neutrophils. Infect. Immun. 1970; 2: 41
   Google Scholar
• Lehrer R. I., Cline M. J. Interaction of Candida albicans with human leukocytes and serum. J. Bacterial. 1969; 98: 998
   Google Scholar
• Taschdjian C., Toni E. F., Jsu K. C., Seelig M. S., Cuestra M. B., Kozinn P. J. Immunofluorescence studies of Candida in human reticuloendothelial phagocytes: implications for immunogenesis and pathogenesis of systemic candidiasis. Am. J. Clin. Pathol. 1971; 56: 50
   PubMedGoogle Scholar
• Hadfield T. L., Marcus S. Macrophage and lymphocyte contributions in resistance to Candida albicans infections. Immunol. Commun. 1982; 11: 201
   PubMed Web of Science ®Google Scholar
• Lehrer R. I. The fungicidal mechanisms of human monocytes. I. Evidence for myeloperoxidase-Iinked and myeloperoxidase-independent candidiacidal mechanisms. J. Clin. Invest. 1975; 55: 338
   PubMed Web of Science ®Google Scholar
• Sasada M., Johnson R. B., Jr. Macrophage microbicidal activity. Correlation between phagocytosis-associated oxidative metabolism and the killing of Candidaby macrophages. J. Exp. Med. 1980; 152: 85
   PubMed Web of Science ®Google Scholar
• Schwocho L. R., Moon R. J. Clearance and killing of Candida albicansin the perfused moflse liver. Mycopalhologia 1981; 76: 175
   PubMedGoogle Scholar
• Williams D., Cook J., Hoffman E., Di Luzio N. Protective effect of glucan in experimentally induced candidiasis. RES J. Reticuhendothel. Soc. 1978; 23: 479
   PubMedGoogle Scholar
• Rogers T., Baiish E. Effect of systemic candidiasis on blastogenesis of lymphocytes from germ-free and conventional rats. Infect. Immun. 1978; 20: 142
   PubMedGoogle Scholar
• Bistoni F., Baccarini M., Blasi F., Puccetti P., Marconi P., Garad E. Correlation between in vivo and in vitro studies of the modulation of resistance to experimental Candida albicans infection by cyclophosphamide in mice. Infect. Immun. 1983; 40: 46
   PubMedGoogle Scholar
• Baccarini M., Bistoni F., Puccetti P., Garaci E. Natural cell-Tnediated cytotoxicity against Candida albicans induced by cyclophosphamide: nature of in vitro cytotoxic effector. Infect. Immun. 1983; 42: 1
   PubMedGoogle Scholar
• Phillips A. W., Baiish E. Growth and invasiveness ofCandida albicansin the germ-free and conventional mouse after oral challenge. Appl. Microbiol. 1966; 14: 737
   PubMedGoogle Scholar
• Balish E., Balish M. J., Salkowki C. A., Lee K. W., Bartizal K. F. Colonization of congenitally athymic gnotobiotic mice by Candida albicans. Appl. Environ. Microbiol. 1984; 47: 647
   PubMedGoogle Scholar
• Carter P. B., Pollard M. Host responses to “normal” microbial flora in germ-free mice. RES J. Reticuhendothel. Soc. 1971; 9: 580
   PubMedGoogle Scholar
• Ueda K., Yamazaki S., Someya S. Impairment and restoration of the delayed type hypersensitivity in germ-free mice. Jpn. J. Microbiol. 1973; 17: 533
   PubMedGoogle Scholar
• Jungi T., McGregor D. Impaired chemotactic responsiveness of macrophages from gnotobiotic rats. Infecl. Immun. 1978; 19: 553
   PubMed Web of Science ®Google Scholar
• Rogers R., Balish E. Immunity to experimental renal candidiasis in rats. Infea. Immun. 1978; 19: 737
   PubMedGoogle Scholar
• Valdimarsson H., Higgs J., Wells R., Yamamura M., Hobbs J., Holt P. Immune abnormalities associated with chronic mucocutaneous candidiasis. Cell. Immunol. 1973; 6: 348
   PubMedGoogle Scholar
• Snyderman R., Altaian L., Frankel A., Flaese R. Defective mononuclear leukocyte chemotaxis: a previously unrecognized immune dysfunction. Ann. Intern. Med. 1973; 78: 509
   PubMedGoogle Scholar
• Djawari D., Simon M., Burkart B. Macrophage functions in patients suffering from chronic mucocutaneous candidiasis. Arch. Dermatol. Res. 1983; 275: 412
   PubMedGoogle Scholar
• Bortolussi R., Faulkner G., Lee S. H. S., Ozere R. Phagocytosis of Candida albicans in chronic mucocutaneous candidiasis. Pediat. Res. 1981; 15: 1287
   PubMedGoogle Scholar
• Fischer A., Pichat L., Audinot M., Griscelli C. Defective handling of mannan by monocytes in patients with chronic mucocutaneous candidiasis resulting in a specific cellular unresponsiveness. Clin. Exp. Immunol. 1982; 47: 653
   PubMedGoogle Scholar
• Diamond K. D., Haudenschild C. C., Erickson N. F., III. Monocyte-mediated damage to Rhizopus oryzaein vitro. Infect. Immun. 1982; 38: 292
   PubMedGoogle Scholar
• Diamond R. D., Huber E., Haudenschild C. C. Mechanisms of destruction of Aspergillus fumigatus hyphae mediated by human monocytes. J. Infect. Dis. 1983; 147: 474
   PubMed Web of Science ®Google Scholar
• Diamond R. D., Krzesicki R., Epstein B., Jao W. Damage to hyphal forms of fungi by human leukocytes in vitro. Am. J. Pathol. 1978; 91: 313
   PubMed Web of Science ®Google Scholar
• Diamond R. D., Haudenschild C. C. Monocyte mediated serum-independent damage to hyphal and pseudohyphal forms of Candida albicans in vitro. J. Clin. Invest. 1981; 67: 173
   PubMed Web of Science ®Google Scholar
• Larrocha C., De Castro Fernandez M., Fontan G., Viloria A., Fernandez-Chacon J., Jimenez C. Hereditary myeloperoxidase deficiency: study of 12 cases. Scand. J. Haematol. 1982; 29: 389
   PubMedGoogle Scholar
• Lehrer R. I. Metabolism and microbicidal function. Ann. Intern. Med. 1978; 88: 79
   Google Scholar
• Babior B. M. Oxygen-dependent microbial killing by phagocytes. N. Engl. J. Med. 1978; 298: 659
   PubMed Web of Science ®Google Scholar
• Drath D. B., Karnovsky M. L. Superoxide production by phagocytic leukocytes. J. Exp. Med. 1975; 141: 257
   PubMed Web of Science ®Google Scholar
• Harrison J. E., Watson B. D., Schultz J. Myeloperoxidase and singlet oxygen: a reappraisal. FEBSlett. 1978; 92: 327
   PubMedGoogle Scholar
• Held A. M., Hurst J. K. Ambiguity associated with use of singlet oxygen trapping agents in myeloperoxidase catalyzed oxidations. Biochem. Biophys. Res. Commun. 1978; 81: 878
   PubMed Web of Science ®Google Scholar
• Diamond R. D. Inhibition of monocyte-mediated damage to fungal hyphae by steroid hormones. J. Infect. Dis. 1983; 147: 160
   PubMed Web of Science ®Google Scholar
• Chow H. S., Sarpet S. C., Epstein R. B. Experimental candidiasis in neutropenic dogs: tissue burden of infection and granulocyte transfusion effects. Blood 1982; 59: 328
   PubMed Web of Science ®Google Scholar
• van Furth R. The origin and turnover of promonocytes, monocytes and macrophages in normal mice. Mononuclear Phagocytes, R. van Furth. Blackwell Scientific, Oxford 1970; 151
   Google Scholar
• Sidransky H., Epstein S. M., Verney E., Horowitz C. Experimental visceral aspergillosis. Am. J. Pathol. 1972; 69: 55
   PubMedGoogle Scholar
• Lehrer R. I., Ladra K. M., Hake R. B. Nonoxidative fungicidal mechanisms of mammalian granulocytes: demonstration of components with candidacidal activity in human, rabbit, and guinea pig leukocytes. Infect. Immun. 1975; 11: 1226
   PubMedGoogle Scholar
• Bjerknes R. Flow cytometric assay for combined measurement of phagocytosis and intracellular killing of Candida albicans. J. Immunol. Meth. 1984; 72: 229
   PubMed Web of Science ®Google Scholar
• Cockayne A., Odds F. C. Interactions of Candida albicans yeast cells, germ tubes, and hyphae with human polymorphonuclear leukocytes in vitro. J. Gen. Microbiol. 1984; 130: 465
   PubMedGoogle Scholar
• Richardson M. D., Smith H. Ultrastructural features of phagocytosis and intracellular killing of Candida albicans by mouse polymorphonuclear phagocyte monolayers. Mycopathologia 1983; 83: 97
   PubMedGoogle Scholar
• Cech P., Lehrer R. I. Heterogeneity of human neutrophil phagolysosomes: function and consequences for candidacidal activity. Blood 1984; 64: 147
   PubMedGoogle Scholar
• Raith L., Csato M., Dobozy A. Decreased Candida albicans killing activity of granulocytes from patients with diabetes mellitus. Mykosen 1983; 26: 557
   PubMedGoogle Scholar
• Bagdade J. D., Root R. I., Bulger R. I. Inpaired leukocyte function in patients with poorly controlled diabetes. Diabetes 1974; 23: 9
   PubMed Web of Science ®Google Scholar
• Miller M. E., Baker L. Leukocyte functions in juvenile diabetes mellitus: humoral and cellular aspects. J. Pediatr. 1972; 81: 979
   PubMedGoogle Scholar
• Csato M., Dobozy A., Simon N. Study of phagocytic function with a quantitative nitroblue-tetrazolium (NBT) reduction test in diabetes mellitus. Arch. Dermatol. Res. 1980; 268: 283
   PubMedGoogle Scholar
• Goldstein D. E., Curnow R. T. Impaired glycogen synthetase activating system in human diabetic polymorphonuclear leukocytes. Diabetes 1982; 29: 217
   Google Scholar
• Klebanoff S. J. Oxygen metabolism and the toxic properties of phagocytes. Ann. Intern. Med. 1980; 93: 480
   PubMed Web of Science ®Google Scholar
• Lehrer R. I. Functional aspects of a second mechanism of candidacidal activity of human neutrophils. J. Clin. Invest. 1972; 51: 2566
   PubMed Web of Science ®Google Scholar
• Lehrer R. I., Cline M. J. Leukocyte myeloperoxidase deficiency and disseminated candidiasis: the role of myeloperoxidase in resistance to Candida infection. J. Clin. Invest. 1969; 48: 1478
   PubMed Web of Science ®Google Scholar
• Vadas M. A., Nicola N., Lopez A. F., Metcalf D., Johnson G., Periera A. Mononuclear cell-mediated enhancement of granulocyte function in man. J. Immunol. 1984; 133: 202
   PubMedGoogle Scholar
• Brummer E., Sugar A. M., Stevens D. A. Immunological activation of polymorphonuclear neutrophils for fungal killing: studies with murine cells and Blastomyces dermalitidis in vitro. J. Leukocyte Biol. 1984; 36: 505
   PubMedGoogle Scholar
• Brummer E., Sugar A. M., Stevens D. A. Enhanced oxidative burst in immunologically activated but not elicited polymorphonuclear leukocytes correlates with fungicidal activity. Infect. Immun. 1985; 49: 396
   PubMedGoogle Scholar
• Lehrer R. I., Jan R. G. Interaction of Aspergillus fumigatus spores with human leukocytes and serum. Infect. Immun. 1970; 1: 345
   PubMedGoogle Scholar
• Levitz S. M., Diamond R. D. Mechanisms of resistance of A. fumigatusconidia to killing by neutrophils in vitro. J. Infect. Dis. 1985; 152: 33
   PubMed Web of Science ®Google Scholar
• McPhail L. C., Henson P. M., Johnston R. B., Jr. Respiratory burst enzyme in human neutrophils: evidence for multiple mechanisms of activation. J. Clin. Invest. 1981; 67: 710
   PubMedGoogle Scholar
• Wilson C. B., Tsai V., Remington J. S. Failure to trigger the oxidative metabolic burst by normal macrophages: possible mechanism for survival of intracellular pathogens. J. Exp. Med. 1980; 151: 328
   PubMed Web of Science ®Google Scholar
• Cole G. T. Architecture and chemistry of the cell wails of higher fungi. Microbiology 1981; 227
   Google Scholar
• Cole G. T., Sekiya T., Kasai R., Yokoyama T., Nozawa Y. Surface ultrastructure and composition of the cell walls of conidial fungi. Exp. Mycol. 1979; 3: 132
   Google Scholar
• Danley D. L., Hilger A. E. Stimulation of oxidative metabolism in murine polymorphonuclear leukocytes by unopsonized fungal cells: evidence for a mannose-specific mechanism. J. Immunol. 1981; 127: 551
   PubMedGoogle Scholar
• Brune K., Leffell M. S., Spitznagel J. K. Microbicidal activity of peroxidaseless chicken het-erophile leukocytes. Infect. Immun. 1972; 5: 283
   PubMed Web of Science ®Google Scholar
• Selsted M. E., Szkiarek D., Ganz T., Lehrer R. I. Activity of rabbit leukocyte peptides against. Candida albicans. Infect. Immun. 1985; 49: 202
   PubMed Web of Science ®Google Scholar
• Lehrer R. I., Szkiarek D., Ganz T., Selsted M. E. Correlation of binding of rabbit granulocyte peptides to Candida albicans with candidacidal activity. Infect. Immun. 1985; 49: 207
   PubMed Web of Science ®Google Scholar
• Diamond R. D., Clark R. A. Damage to Aspergillus fumigatus and Rhizopus oryzae hyphae by oxidative and nonoxidative microbicidal products of human neutrophils in vitro. Infect. Immun. 1982; 38: 487
   PubMed Web of Science ®Google Scholar
• Diamond R. D., Clark R. A., Haudenschild C. C. Damage to Candida albicans hyphae and psuedohyphae by the myeloperoxidase system and oxidative products of neutrophil metabolism in vitro. J. Clin. Invest. 1980; 66: 908
   PubMed Web of Science ®Google Scholar
• Diamond R. D., Krzesicki R., Jao W. Damage to pseudohyphal forms of Candida albicans by neutrophils in the absence of serum in vitro. J. Clin. Invest. 1978; 61: 349
   PubMed Web of Science ®Google Scholar
• Diamond R. D., Krzesicki R. Mechanisms of attachment of neutrophils to Candida albicans pseudohyphae in the absence of serum, and of subsequent damage to pseudohyphae by microbicidal processes of neutrophils in vitro. J. Clin. Invest. 1978; 61: 360
   PubMed Web of Science ®Google Scholar
• Waldorf A. R., Diamond R. D. Generation of serum chemotactic factors for neutrophils by Rhizopus spores andAspergillus conidia. Infect. Immun. 1985; 48: 458
   PubMed Web of Science ®Google Scholar
• Chinn R. Y. W., Diamond R. D. Generation of chemotactic factors by Rhizopus oryzae in the presence and absence of serum: relationship to hyphal damage mediated by human neutrophils and effects of hyperglycemia and ketoacidosis. Infect. Immun. 1982; 381: 1123
   Google Scholar
• Marx R. D., Forsyth K. R., Hentz S. K. Muocrales species activation of a serum leukotactic factor. Infect. Immun. 1982; 38: 1217
   PubMedGoogle Scholar
• Wilkinson P. C. Recognition of protein structure in leukocyte chemotaxis. Nature (London) 1973; 244: 512
   PubMedGoogle Scholar
• Wilkinson P. C. Recognition and response in mononuclear and granular phagocytes. Clin. Exp. Immunol. 1976; 25: 355
   PubMedGoogle Scholar
• Ekundayo J. A., Carlile M. J. The germination of sporangiospores of Rhizopus arrhizus; spore swelling and germ tube emergence. J. Gen. Microbiol. 1964; 35: 261
   PubMedGoogle Scholar
• Miyachi Y., Horio T., Imamurh S. The fate of experimental cutaneous candidiasis in guinea pigs under the suppressed polymorphonuclear leukocyte chemotaxis by colchicine. Arch. Dermatol. Res. 1981; 271: 373
   PubMedGoogle Scholar
• Corbel M. J., Eades S. M. Examination of the effect of age and acquired immunity on the susceptibility of mice to infection with A. fumigatus. Mycopathologia 1977; 60: 79
   PubMed Web of Science ®Google Scholar
• Willers J. M. Q., Sluis E. The influence of cyclophosphamide on antibody formation in the mouse. Ann. Immunol. (Inst Pasteur) 1975; 126C: 267
   Google Scholar
• Lehman P. F., White L. O. Acquired immunity to A. fumigatus. Infect. Immun. 1978; 13: 1296
   Google Scholar
• Lehman P. F., White L. O. Chitin assay used to demonstrate renal localization and cortisone-enhanced growth of A. fumigatus mycelium in mice. Infect. Immun. 1975; 12: 987
   PubMedGoogle Scholar
• Lehman P. F. 1982, personal communication
   Google Scholar
• Gale G. R., Weicb A. Studies of opportunistic fungi. I. Inhibition ofR. oryzae by human sera. Am. J. Med. Sci. 1961; 45: 604
   Google Scholar
• Owens A. W., Hacklette M. S., Baker R. D. An antifungal factor in human serum. I. Studies of Rhizopus rhizopodiformis. Sabouraudia 1965; 4: 179
   PubMedGoogle Scholar
• Eng R. H. K., Corrado M., Chin E. Susceptibility of zygomycetes to human serum. Sabouraudia 1981; 19: 111
   PubMedGoogle Scholar
• Polli V. C., Diekmann H., Kis Z., Ettlinger L. Uber das Vorkommen von Ketonreduktasen bei Mikroorganismen. Pathol. Microbiol. 1965; 28: 93
   PubMedGoogle Scholar
• Waldorf A. R. 1984, unpublished data
   Google Scholar
• Sheldon W. H., Bauer H. The development of the acute inflammatory response to experimental cutaneous mucormycosis in normal and diabetic rabbits. J. Exp. Med. 1959; 110: 845
   PubMed Web of Science ®Google Scholar
• Artis W. M., Fountain J. A., Delcher H. K., Jones H. E. A mechanism of susceptibility to mucormycosis in diabetic ketoacidosis: transferrin and iron availability. Diabetes 1982; 31: 1109
   PubMed Web of Science ®Google Scholar
• Artis M. M., Patrusky E., Rastinejad F., Duncan R. L., Jr. Fungistatic mechanism of human transferrin for R. oryzae and Trichophyton mentagrophyesalternative to simple iron deprivation. Infect. Immun. 1983; 41: 1269
   PubMedGoogle Scholar
• Corbel M. J., Eades S. M. Experimental phycomycosis in mice; examination of the role of acquired immunity in resistance to Absidia ramosa. J. Hyg. Comb. 1976; 77: 221
   PubMedGoogle Scholar
• Waldorf A. R., Halde C., Vedros N. A. Passive immunization in murine mucormycosis. Mycopathologia 1983; 83: 149
   PubMedGoogle Scholar
• Smith J., Louria D. Ami-Candida factors in serum and their inhibitors. II. Identification of a Candida-clumping factor and the influence of the immune response on the morphology of Candida and on anti-Candidaactivity of serum in rabbits. J. Infect. Dis. 1972; 125: 115
   PubMedGoogle Scholar
• Katsura Y., Uesaka I. Assessments of germ tube dispersion activity of serum from experimental candidiasis: a new procedure for diagnosis. Infect. Immun. 1974; 9: 788
   PubMedGoogle Scholar
• Chilgren R. A., Hong R., Quie P. G. Human serum interactions with Candida albicans. J. Immunol. 1968; 101: 128
   PubMedGoogle Scholar
• Kirkpatrick C., Green I., Rich R., Schade A. Inhibition of growth ofCandida albicansby iron-unsaturated lactoferrin: relation to host-defense mechanisms in chronic mucocutaneous candidiasis. J. Infect. Dis. 1971; 124: 539
   PubMed Web of Science ®Google Scholar
• Weinberg E. Iron and susceptibility to infectious disease. Science 1974; 184: 952
   PubMed Web of Science ®Google Scholar
• Abe F., Tateyma M., Shibuya H., Azumi N., Ommura Y. Experimental candidiasis in iron overload. Mycopathologia 1985; 85: 59
   Google Scholar
• Rennie J. S., Hutcheon A. W., MacFarlane T. W., MacDonald G. The role of iron deficiency in experimentally induced oral candidiasis in the rat. J. Med. Microbiol. 1983; 16: 363
   PubMedGoogle Scholar
• Morelli R., Rosenberg L. T. The role of complement in the phagocytosis ofCandida albicansby mouse peripheral blood leukocytes. J. Immunol. 1971; 7: 476
   Google Scholar
• Hector R. F., Domer J. E., Carrow E. W. Immune responses to Candida albicans in genetically distinct mice. Infect. Immun. 1982; 38: 1020
   PubMed Web of Science ®Google Scholar
• Kagaya K., Shnoda T., Fukazawa Y. Murine defense mechanisms against Candida albicans infection. I. Collaboration of cell mediated and humoral immunities in protection against systemicCandida albicansinfection. Microbiol. Immunol. 1981; 25: 647
   PubMedGoogle Scholar
• Dobias B. Specific and nonspecific immunity in Candida infections. Acta Med. Scand. 1964; 176: 4
   Google Scholar
• AJ-Dorry Y. An immune factor in baboon anti-Candida serum. Sabouraudia 1970; 8: 31
   Google Scholar
• Pearsall N., Adams B., Bunni R. Immunologic responses to Candida albicans. III. Effects of passive transfer of lymphoid cells or serum on murine candidiasis. J. Immunol. 1978; 120: 1176
   PubMed Web of Science ®Google Scholar
• Carrow E. W., Hector R. F., Domer J. E. Immunodeficient CBA/N mice respond effectively to Candida albicans. Clin. Immunol. Immunopathol. 1984; 33: 371
   PubMedGoogle Scholar
• Scher I. CBA/N immune defective mice—evidence for failure of B-plasma cell to be expressed. Immunol. Rev. 1982; 64: 117
   PubMedGoogle Scholar
• Perera H. A., Hosking C. S. The role of complement and antibody in opsonization and intracellular killing of Candida albicans. Clin. Exp. Immunol. 1984; 57: 307
   PubMedGoogle Scholar
• Howie J. B., Helyer B. J. The immunology and immunopathology of NZB mice. Adv. lmmun. 1968; 9: 215
   Google Scholar
• Waldmann T. A., Balaesc R. M., Broder S., Krakauer S. Disorders of suppressor immunor-egulatory cells in the pathogenesis of immunodeficiency and autoimmunity. Ann. Intern. Med. 1978; 88: 226
   PubMed Web of Science ®Google Scholar
• Corbel M. J., Eades S. M. The relative susceptibility of New Zealand Black and CBA mice to infection with opportunistic fungal pathogens. Sabouraudia 1976; 14: 17
   PubMedGoogle Scholar
• James K., Milne I. The effect of anti-lymphocytic antibody on the humoral immune response in different strains of mice. I. The response to bovine serum albumin. Immunology 1972; 23: 897
   PubMedGoogle Scholar
• Corbel M. J., Eades S. M. Factors determining the susceptibility of mice to experimental phyco-mycosis. J. Med. Microbiol. 1975; 8: 551
   PubMedGoogle Scholar
• Kirkpatrick C. H., Rich R. R., Bennett J. E. Chronic mucocutaneous candidiasis: modei-building in cellular immunity. Ann. Intern. Med. 1971; 74: 955
   PubMed Web of Science ®Google Scholar
• Provost T., Garrettson L., Zeschke R., Rose N., Tomasi T. Combined immune deficiency, autoantibody formation, and chronic mucocutaneous candidiasis. Clin. Immunol, fmmunopathol. 1973; 1: 429
   PubMedGoogle Scholar
• Giger O., Domer J., Moser S., McQuitty J. Experimental murine Candida: pathological and immune responses in T lymphocyte-depleted mice. Infect, lmmun. 1978; 21: 729
   PubMedGoogle Scholar
• Miyake T., Takeya K., Nomoto K., Muraoka J. Cellular elements in the resistance to Candida infection in mice.I. Contribution of T lymphocytes and phagocytes at various stages of infection. Microbiol. Immunol. 1977; 21: 703
   PubMedGoogle Scholar
• Carrow E. W., Domer J. E. Immunoregulation in experimental murine candidiasis: specific suppression induced byCandida albicanscell wall glycoprotein. Infect, Immun. 1985; 49: 172
   PubMedGoogle Scholar
• Marra S., Balish E. Immunity to Candida albicans induced by Listeria monocytogenes. Infect. lmmun. 1974; 10: 72
   PubMedGoogle Scholar
• Cutler J. E. Acute systemic candidiasis in normal and congenitally thymus-deficient (nude) mice. RES J. Reticuloendothel. Soc. 1976; 19: 121
   PubMedGoogle Scholar
• Rogers T., Balish E., Manning D. The role of thymus-dependent cell-mediated immunity in resistance to experimental disseminated candidiasis. RES J. Reticuloendothel. Soc. 1976; 20: 291
   PubMedGoogle Scholar
• Tabeta H., Mikami Y., Abe F., Ommura Y., Arai T. Studies on defense mechanisms against Candida albicans infection in congenitally athymic nude (nu/nu) mice. Mycopathologia 1984; 84: 107
   PubMed Web of Science ®Google Scholar
• Cheers C., Waller R. Activated macrophages in congenitally athymic “nude” mice and in lethally irradiated mice. J. Immunol. 1975; 115: 844
   PubMedGoogle Scholar
• Pore R., Larsh H. W. Experimental pathogenicity of Aspergillus terreus-flavipes group species. Sabouraudia 1968; 6: 89
   PubMedGoogle Scholar
• Ford S., Friedman L. Experimental study of the pathogenicity of aspergilli for mice. J. BacterioL. 1967; 94: 928
   PubMed Web of Science ®Google Scholar
• Rippon J. W., Anderson D. N., Soo Hoo M. Aspergillosis: comparative virulence, metabolic rate, growth rate and ubiquinone content of soil and human isolates of Aspergillus terreus. Sabouraudia 1971; 12: 157
   Google Scholar
• Kitz D. J., Embree R. W., Cazin J., Jr. Comparative virulence of Absidia corymbifera strains in mice. Infect. Immun. 1981; 33: 395
   PubMedGoogle Scholar
• Kitz D. J., Embree R. W., Cazin J., Jr. Radiomyces a genus in the Mucorales pathogenic for mice. Sabouraudia 1980; 18: 115
   PubMedGoogle Scholar
• Borg M., Kirk D., Baumgarten H., Ruchel R. A colormetric assay for the assessment of cytotoxicity of yeasts. Sabouraudia 1984; 22: 357
   PubMedGoogle Scholar
• Klotz S. A., Drutz D. J., Harrison J. L., Huppert M. S. Adherence and penetration of vascular endothelium by Candida yeasts. Infect, Immun. 1983; 42: 374
   PubMed Web of Science ®Google Scholar
• Macura A. B., Pawlik B., Wita B. Candida adherence to mucosal epithelial cells with regard to pathogenicity. Zbl. Bala. Hyg. I Abt. Org. A 1983; 254: 561
   Google Scholar
• Ray T. L., Dirge K. B., Payne C. D. Adherence of Candida species to human epidermal comeocytes and buccal mucosal cells: correlation with cutaneous pathogenicity. J. Invest. Dermatol. 1984; 83: 37
   PubMedGoogle Scholar
• Loose D. S., Stevens D. A., Schurman D. J., Feldman D. Distribution of a corticosteroid-binding protein in Candida and other fungal genera. J. Gen. Microbiol. 1983; 129: 2379
   PubMedGoogle Scholar
• Powell B. L., Drutz D. J. Confirmation of corticosterone and progesterone binding activity in Candida albicans. J. Infect. Dis. 1983; 147: 359
   PubMedGoogle Scholar
• Powell B. L., Frey C. L., Drutz D. J. Identification of a 17 B-estradiol binding protein inCandida albicansand Candida glabrata. Exp. Mycol. 1984; 8: 304
   Google Scholar
• Calderone R. A., Lchrer N., Segal E. Adherence of Candida albicans to buccal and vagina] epithelial cells: ultrastructural observations. Can. J. Microbiol. 1984; 30: 1001
   PubMed Web of Science ®Google Scholar
• McCourtie J., Douglas L. J. Relationship between cell surface compositon. adherence and virulence of Candida albicans. Infect. Immun. 1984; 45: 6
   PubMed Web of Science ®Google Scholar
• Tronchin G., Poulan D., Vernes A. Cytochemical and ultrastructural studies of Candida albicans. Arch. Microbiol. 1984; 139: 221
   PubMed Web of Science ®Google Scholar
• Segal E., Soroka A., Lehrer N. Attachment of Candida to mammalian tissues—clinical and experimental studies. Zbl. Bakt. Hyg. A 1984; 257: 257
   PubMedGoogle Scholar
• Skerl T. C., Calderon R. A., Segal E., Sreevalsan T., Scheld W. M. In vitro binding of Candida albicans yeast cells to human fibronectin. Can. J. Microbiol. 1984; 30: 221
   PubMed Web of Science ®Google Scholar
• Tilden E. B., Hulton E. H., Freeman S., Williamson W. H., Koenig V. L. Preparation and properties of the endotoxin from A. fumigatus and Aspergillus flavus. Mycopalhol. Mycol. Appl. 1961; 24: 324
   Google Scholar
• Longbottom J. L., Pepys J. Pulmonary aspergillosis diagnostic and immunological significance of antigens and C-reactive substance in Aspergillus fumigatus. J. Pathol. Bacterial. 1964; 88: 141
   PubMedGoogle Scholar
• Yamazaki M., Suzuki S., Miyaki K. Tremorgenic toxins from Aspergillus fumigatus. Fres. Chem. Pharm. Bull. 1971; 19: 1739
   PubMed Web of Science ®Google Scholar
• Chaudhary B., Singh B. Role of endotoxin of Aspergillus fumigatus in its pathogenicity. Mykosen 1982; 26: 430
   Google Scholar
• Kothary M. H., Chase T., Jr., Macmillan J. D. Correlation of elastase production by some strains of Aspergillus fumigatus with ability to cause pulmonary invasive aspergillosis in mice. Infect. Immun. 1984; 43: 320
   PubMed Web of Science ®Google Scholar
• Mullbacher A., Eichner R. D. Immunosuppression in vitro by a metabolite of a human pathogenic fungus. Proc. Natl. Acad. Sci. U.S.A. 1984; 81: 3835
   PubMed Web of Science ®Google Scholar
• Ruchel R., Uhleman K., Boning B. Secretion of acid proteinases by different species of the genus Candida. ZBl. Bakt. Hyg. I Abt. Org. A 1983; 155: 337
   Google Scholar
• Ruchel R. A variety of Candida proteinases and their possible targets of proteolytic attack in the host. Zbl. Bakt. Hyg. A 1984; 257: 266
   PubMedGoogle Scholar
• MacDonald F., Odds F. C. Inducible proteinase of Candida albicans in diagnostic serology and in the pathogenesis of systemic candidiasis. J. Med. Microbiol. 1980; 13: 423
   PubMed Web of Science ®Google Scholar
• MacDonald F., Odds F. C. Virulence for mice of a proleinase-secreting strain of Candida albicans and a protein-deficient mutant. J. Gen. Microbiol. 1983; 129: 431
   PubMedGoogle Scholar
• Ruchel R. On the renin-like activity of Candida proteinases and activation of blood coagulation in vitro. Zbl. Bakt. Hyg. I. Abt. Org. A 1983; 255: 368
   Google Scholar
• Schreiber B., Lyman C. A., Gurevich J., Needham C. A. Proteolytic activity of Candida albicans and other yeasts. Diag. Microbiol. Infect. Dis. 1985; 3: 1
   PubMedGoogle Scholar
• Banno Y., Yamada T., Nozawa Y. Secreted phospholipases of the dimorphic fungus Candida albicans: separation of three enzymes and some biological properties. Sabouraudia 1985; 23: 47
   PubMedGoogle Scholar
• Price M. F., Wilkinson I. D., Gentry L. O. Plate method for detection of phospholipase activity in Candida albicans. Sabouraudia 1982; 15: 179
   Google Scholar
• Richardson M. D., Smith H. Production of germ tubes by virulent and attenuated strains of Candida albicans. J. Infect. Dis. 1981; 144: 565
   PubMed Web of Science ®Google Scholar
• Diamond R. D., Oppenheim F., Nakagawa Y., Krzesicki R., Haudenschild C. C. Properties of a product of Candida albicans hyphae and pseudohyphae that inhibits contact between the fungi and human neutrophils in vitro. J. Immunol. 1980; 125: 2797
   PubMed Web of Science ®Google Scholar
• Rivas V., Rogers T. J. Studies on the cellular nature of Candida albicans induced suppression. J. Immunol. 1983; 130: 376
   PubMed Web of Science ®Google Scholar
• Sobel J. D., Muller G., Buckley H. R. Critical role of germ tube formation in the pathogenesis of Candidal vaginitis. Infect. Immun. 1984; 44: 576
   PubMed Web of Science ®Google Scholar
• Buffo J., Herman M. A., Soil D. R. A characterization of pH regulated dimorphism in Candida albicans. Mycopathologia 1984; 85: 21
   PubMed Web of Science ®Google Scholar
• Walker G. M., Sullivan P. A., Shephards M. G. Magnesium and the regulation of germ tube formation in Candida albicans. J. Gen. Microbiol. 1984; 130: 1941
   PubMedGoogle Scholar
• Manning M., Snoddy C. B., Fromtling R. A. Comparative pathogenicity of auxotrophic mutants of Candida albicans. Can. J. Microbiol. 1984; 30: 31
   PubMedGoogle Scholar